ITPS Canada Achieves NATO Flight Training Europe Accreditation 
Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange and Montreal Exchange Closed for Labour Day 
Doubleview Appoints Edward Huebert as Vice President, Permitting, Regulatory & Indigenous Relations 
Focus Graphite and C4V to Evaluate Mine-to-Anode Platform Combining Lac Knife Graphite with C4V’s Green Anode Technology 
Spritzer Sparkling Invites Malaysians to ‘Reset Rasa’ This Merdeka, Rediscover the Flavours That Unite Us Provenir Recognized as Best Credit Risk Solution in the Global BankTech Awards 2023
The awards program celebrates the world’s most cutting-edge vendor and solution providers transforming the financial…
SecurityScorecard Joins Forces with Measured Analytics and Insurance to Deliver Industry-First Cyber Insurance Discounts for Top Security Ratings
Continuous cyber risk assessments with actionable threat mitigation plans reduce breach likelihood and financial vulnerability…
Data Kinetic Launches Applied AI Solutions Suite for the Oil and Gas Industry
New Solution Suite delivers Applied AI engineering to improve processes and profitability for oil and…
KRYZ LP FM Radio Adopts Atsign’s Networking 2.0 Infrastructure and SSH No Ports to Secure Radio Tower Operations
Station Implements Major Security Improvements After Radio Station’s Programming Disrupted with Scandinavian Rock MARIPOSA, Calif.,…
Rackspace Technology Taps Palo Alto Networks for Comprehensive Cybersecurity Solutions
Strengthening customers’ ability to stay ahead of evolving cyber threats SAN ANTONIO , Sept. 13,…
KRYZ LP FM Radio Adopts Atsign’s Networking 2.0 Infrastructure and SSH No Ports to Secure Radio Tower Operations
Station Implements Major Security Improvements After Radio Station’s Programming Disrupted with Scandinavian Rock MARIPOSA, Calif.,…
Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Declared the New Successful Bidder
PALO ALTO, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”…
Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Declared the New Successful Bidder
PALO ALTO, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”…
Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine
Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating…
Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine
Supply of drug substance manufactured under cGMP supports first-in-human clinical study for RBI-4000 novel self-replicating…
HOOKIPA Announces Executive Leadership Change
NEW YORK and VIENNA, Sept. 13, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK,…
HOOKIPA Announces Executive Leadership Change
NEW YORK and VIENNA, Sept. 13, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK,…
IMUNON Reminds Investors of its Virtual R&D Day Tomorrow at 4:00 p.m. ET
Program will feature executive management plus key opinion leaders in immuno-oncology and vaccine development LAWRENCEVILLE,…
IMUNON Reminds Investors of its Virtual R&D Day Tomorrow at 4:00 p.m. ET
Program will feature executive management plus key opinion leaders in immuno-oncology and vaccine development LAWRENCEVILLE,…
NurExone Moves Forward Towards Human Clinical Trials, Completes Pre-IND Meeting with the FDA for Proprietary ExoPTEN Drug
The FDA’s response indicated that the planned toxicity study strategy is acceptable under FDA guidelines…
NurExone Moves Forward Towards Human Clinical Trials, Completes Pre-IND Meeting with the FDA for Proprietary ExoPTEN Drug
The FDA’s response indicated that the planned toxicity study strategy is acceptable under FDA guidelines…
Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20th
SOLANA BEACH, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical…
Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20th
SOLANA BEACH, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical…
Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)
Favorable safety and tolerability profile of OCU400 investigational drug product in RP and LCA subjects…
Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)
Favorable safety and tolerability profile of OCU400 investigational drug product in RP and LCA subjects…